Naoya Akazawa
Articles
-
Sep 16, 2024 |
nature.com | Yoshiaki Nakamura |Jun Watanabe |Naoya Akazawa |Kozo Kataoka |Yoshinori Kagawa |Kun-Huei Yeh | +10 more
AbstractThe interim analysis of the CIRCULATE-Japan GALAXY observational study demonstrated the association of circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) detection with recurrence risk and benefit from adjuvant chemotherapy (ACT) in resectable colorectal cancer (CRC).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →